BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12957874)

  • 1. Receptor-regulated Smads in TGF-beta signaling.
    Liu F
    Front Biosci; 2003 Sep; 8():s1280-303. PubMed ID: 12957874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
    Alvarez J; Serra R
    Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
    Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
    EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
    Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
    Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
    Fink SP; Mikkola D; Willson JK; Markowitz S
    Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta signaling in colon cancer cells.
    Li F; Cao Y; Townsend CM; Ko TC
    World J Surg; 2005 Mar; 29(3):306-11. PubMed ID: 15711891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.
    Lagna G; Hata A; Hemmati-Brivanlou A; Massagué J
    Nature; 1996 Oct; 383(6603):832-6. PubMed ID: 8893010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
    Zhang Y; Musci T; Derynck R
    Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells.
    Bondestam J; Kaivo-oja N; Kallio J; Groome N; Hydén-Granskog C; Fujii M; Moustakas A; Jalanko A; ten Dijke P; Ritvos O
    Mol Cell Endocrinol; 2002 Sep; 195(1-2):79-88. PubMed ID: 12354674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
    Feng XH; Lin X; Derynck R
    EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into TGF-beta-Smad signalling.
    ten Dijke P; Hill CS
    Trends Biochem Sci; 2004 May; 29(5):265-73. PubMed ID: 15130563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking Smads and transcriptional activation.
    Inman GJ
    Biochem J; 2005 Feb; 386(Pt 1):e1-e3. PubMed ID: 15702493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A component of the ARC/Mediator complex required for TGF beta/Nodal signalling.
    Kato Y; Habas R; Katsuyama Y; Näär AM; He X
    Nature; 2002 Aug; 418(6898):641-6. PubMed ID: 12167862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling.
    Yu J; Zhang L; Chen A; Xiang G; Wang Y; Wu J; Mitchelson K; Cheng J; Zhou Y
    J Cell Physiol; 2008 May; 215(2):422-33. PubMed ID: 17960585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
    Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
    Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.